These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9350074)

  • 1. Minimal residual disease in B-lymphoproliferative disorders by PCR detection of immunoglobulin heavy chain gene recombination.
    Petroni D; Saglio G
    Scand J Clin Lab Invest; 1997 Oct; 57(6):541-7. PubMed ID: 9350074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of immunoglobulin gene rearrangement in lymphoid malignancies of B-cell lineage by seminested polymerase chain reaction gene amplification.
    Liang R; Chan V; Chan TK; Wong T; Chiu E; Lie A; Todd D
    Am J Hematol; 1993 May; 43(1):24-8. PubMed ID: 8317459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of antigen receptor gene rearrangements in lymphoproliferative malignancies by fluorescent polymerase chain reaction.
    Kerlan-Candon S; Soua Z; Lefranc MP; Clot J; Eliaou JF
    Tissue Antigens; 1998 Jan; 51(1):20-9. PubMed ID: 9459500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Profile of immunoglobulin heavy chain variable gene repertoires and highly selective detection of malignant clonotypes in acute lymphoblastic leukemia.
    Greenberg SJ; Choi Y; Ballow M; Du TL; Ward PM; Rickert MH; Frankel S; Bernstein SH; Brecher ML
    J Leukoc Biol; 1995 Jun; 57(6):856-64. PubMed ID: 7790768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoglobulin heavy-chain consensus probes for real-time PCR quantification of residual disease in acute lymphoblastic leukemia.
    Donovan JW; Ladetto M; Zou G; Neuberg D; Poor C; Bowers D; Gribben JG
    Blood; 2000 Apr; 95(8):2651-8. PubMed ID: 10753847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of minimal residual disease in acute lymphoblastic leukemia using immunoglobulin hypervariable region specific oligonucleotide probes.
    Jonsson OG; Kitchens RL; Scott FC; Smith RG
    Blood; 1990 Nov; 76(10):2072-9. PubMed ID: 2122920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of T-cell receptor delta gene rearrangement in T-cell malignancies by clonal specific polymerase chain reaction and its application to detect minimal residual disease.
    Chan DW; Liang R; Kwong YL; Chan V
    Am J Hematol; 1996 Jul; 52(3):171-7. PubMed ID: 8756082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variable rate of detection of immunoglobulin heavy chain V-D-J rearrangement by PCR: a systematic study of 41 B-cell non-Hodgkin's lymphomas and leukemias.
    Ben-Ezra J
    Leuk Lymphoma; 1992 Jul; 7(4):289-95. PubMed ID: 1493428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of immunoglobulin heavy chain variable genes in B-chronic lymphocytic leukemia.
    Bertin P; Risueño C; Meller C
    Ann N Y Acad Sci; 1995 Sep; 764():474-7. PubMed ID: 7486569
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation of residual disease in B-cell chronic lymphocytic leukemia patients in clinical and bone-marrow remission using CD5-CD19 markers and PCR study of gene rearrangements.
    Vuillier F; Claisse JF; Vandenvelde C; Travade P; Magnac C; Chevret S; Desablens B; Binet JL; Dighiero G
    Leuk Lymphoma; 1992 Jun; 7(3):195-204. PubMed ID: 1282428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular detection and characterization of clonal cell populations in acute lymphocytic leukemia by analysis of conformational polymorphisms of cRNA molecules of rearranged T-cell-receptor-gamma and immunoglobulin heavy-chain genes.
    Koch OM; Volkenandt M; Göker E; Buer J; Probst M; Banerjee D; Danenberg PV; Bertino JR
    Leukemia; 1994 Jun; 8(6):946-52. PubMed ID: 8207989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoglobulin heavy chain variable region family usage is independent of tumor cell phenotype in human B lineage leukemias.
    Deane M; Norton JD
    Eur J Immunol; 1990 Oct; 20(10):2209-17. PubMed ID: 1700749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minimal residual disease detection in B-cell malignancies by assessing IgH rearrangement.
    Maloum K; Pritsch O; Dighiero G
    Hematol Cell Ther; 1997 Jun; 39(3):119-24. PubMed ID: 9262987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minimal residual disease in hairy cell leukemia patients assessed by clone-specific polymerase chain reaction.
    Arons E; Margulies I; Sorbara L; Raffeld M; Stetler-Stevenson M; Pastan I; Kreitman RJ
    Clin Cancer Res; 2006 May; 12(9):2804-11. PubMed ID: 16675574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Size and frequency of the DNA fragments in the rearranged immunoglobulin heavy chain joining regions in the lymphocytic leukemias.
    Stolc V; Uhrmacher J; Krause JR
    Anticancer Res; 1991; 11(2):813-6. PubMed ID: 1905906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia. European Organization for Research and Treatment of Cancer--Childhood Leukemia Cooperative Group.
    Cavé H; van der Werff ten Bosch J; Suciu S; Guidal C; Waterkeyn C; Otten J; Bakkus M; Thielemans K; Grandchamp B; Vilmer E
    N Engl J Med; 1998 Aug; 339(9):591-8. PubMed ID: 9718378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of minimal residual disease in B-lymphoproliferative disorders: a three step SSCP-PCR method.
    Miglino M; Grasso R; Pietrasanta D; Palmisano GL; Berisso G; Clavio M; Pierri I; Santini G; Canepa L; Gobbi M
    J Exp Clin Cancer Res; 2001 Mar; 20(1):95-101. PubMed ID: 11370837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Graft-versus-leukemia activity may overcome therapeutic resistance of chronic lymphocytic leukemia with unmutated immunoglobulin variable heavy-chain gene status: implications of minimal residual disease measurement with quantitative PCR.
    Ritgen M; Stilgenbauer S; von Neuhoff N; Humpe A; Brüggemann M; Pott C; Raff T; Kröber A; Bunjes D; Schlenk R; Schmitz N; Döhner H; Kneba M; Dreger P
    Blood; 2004 Oct; 104(8):2600-2. PubMed ID: 15205268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A clinical perspective on immunoglobulin heavy chain clonal heterogeneity in B cell acute lymphoblastic leukemia.
    Fries C; Burack WR
    Leuk Res; 2018 Dec; 75():15-22. PubMed ID: 30445235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and structural analysis of rearranged immunoglobulin heavy chain genes in lymphomas and leukemias.
    Linke B; Pyttlich J; Tiemann M; Suttorp M; Parwaresch R; Hiddemann W; Kneba M
    Leukemia; 1995 May; 9(5):840-7. PubMed ID: 7769847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.